Category: cancer
Proclamation Heralds Worldwide Neuroendocrine Tumor (NET) Cancer Awareness Day: November 10, 2010
To raise greater awareness of neuroendocrine tumor (NET) cancers the first annual Worldwide NET Cancer Awareness Day is being planned for Wednesday, November 10, 2010. In preparation for this unique day, a proclamation has been created by the World…
READ MORECarcinoid & Neuroendocrine Tumor Patients Invited to FDA Public Hearing
For carcinoid and neuroendocrine tumor patients who would like their voices to be heard regarding the Food and Drug Administration’s (FDA) regulation of drugs, biologics, and devices for the diagnosis and treatment of rare diseases, you are invited…
READ MOREY-90 Radiomicrosphere Therapy Workshop To Be Offered in Florida
Carcinoid and neuroendocrine cancer patients interested in learning more about Y-90 radiomicrosphere therapy can join physicians, scientists, and technologists for a workshop being presented by “Advances in Minimally Invasive Treatments” International…
READ MOREMultiple Endocrine Neoplasias (MEN) Patient Education Conference to Be Held at MD Anderson Cancer Center in June
MEN, carcinoid, and neuroendocrine tumor patients, family members, advocacy groups, physicians, and caregivers are invited to attend MD Anderson Cancer Center’s Multiple Endocrine Neoplasias Patient Education Conference on Saturday, June 26,…
READ MOREFree Education Workshops for Carcinoid Cancer & Neuroendocrine Tumor Patients
Carcinoid and neuroendocrine cancer patients have a wonderful resource in CancerCare, a national nonprofit organization that provides free, professional support services for anyone affected by cancer. “CancerCare’s free Connect® Education …
READ MORECanadian Report Card on Cancer Features Carcinoid and Neuroendocrine Cancers
An article by Maureen Coleman, President of the Carcinoid Neuro-Endocrine Tumour Society (CNETS) Canada www.cnetscanada.org, on carcinoid and neuroendocrine cancers is featured in the rare cancers section of the 2009-2010 Report Card on Cancer …
READ MORE